We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1803:TSEBeijing Sports and Entertainment Industry Group Limited Analysis

Data as of 2026-06-17 - not real-time

¥2,563.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shimizu Corporation appears notably undervalued relative to its industry peers, with a price‑earnings multiple well below the sector average and an attractive dividend yield supported by a comfortable payout ratio. Technical signals are supportive, as the stock trades just above its 20‑day simple moving average, the MACD histogram is positive and the MACD signal is bullish, while the relative strength index sits in a neutral zone, suggesting limited short‑term downside. The discounted cash‑flow model implies a meaningful upside potential, and the current market price remains comfortably above the identified support level yet below the near‑term resistance, positioning the stock for a possible rally.
On the risk side, the stock exhibits high recent volatility but a low beta, indicating that broader market swings drive price movements more than company‑specific factors. The balance sheet carries a high debt load and free cash flow is currently negative, which tempers confidence despite solid operating cash flow and a sustainable dividend. Overall, the blend of value metrics, dividend appeal, and bullish technical cues outweighs the financial leverage concerns, making the stock a compelling candidate for investors with a moderate risk tolerance.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Bullish MACD crossover
  • Price positioned just above the 20‑day SMA
  • DCF‑derived upside potential

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low PE relative to industry
  • Attractive dividend yield
  • High debt level and negative free cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend policy
  • Sector recovery prospects
  • Low beta reducing market‑wide volatility exposure

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin6.15%
P/E Ratio13.7
ROE13.41%
ROA2.86%
Debt/Equity56.67
P/B Ratio1.8
Op. Cash Flow¥41.6B
Free Cash Flow¥-89538248704
Industry P/E31.2

Technical Analysis

TrendNeutral
RSI46.8
Support¥2,371.00
Resistance¥2,829.00
MA 20¥2,557.80
MA 50¥2,770.88
MA 200¥2,630.75
MACDBullish
VolumeStable
Fear & Greed Index88.5

Valuation

Fair Value¥309.94
Target Price¥3,114.29
Upside/Downside21.49%
GradeUndervalued
TypeValue
Dividend Yield2.92%

Risk Assessment

Beta0.24
Volatility68.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.